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The effect of safety behaviour on the acceptability of exposure therapy  
for contamination fear 
Hannah C. Levy 
Compulsive washing and contamination fear are among the most common 
symptoms of obsessive-compulsive disorder (OCD). Research suggests that exposure and 
response prevention (ERP) is effective for OCD; however, ERP is prone to dropouts and 
refusals, and a substantial proportion of clients do not receive the care they need. A 
proposed solution involves the judicious use of safety behaviour to enhance the 
acceptability of ERP. The current study aimed to test this proposed solution. Participants 
were 70 undergraduate students who completed two brief exposure-based treatment 
sessions for contamination fear, one with safety behaviour and one without. Following 
each session, participants rated the acceptability of the treatment in which they had just 
engaged. Exposure with safety behaviour (ESB) was rated as significantly more 
acceptable than exposure and response prevention (ERP). Furthermore, subjective fear 
ratings were significantly lower and behavioural approach to a series of contaminants was 
significantly greater in the ESB condition. Results are discussed in terms of the 
conceptualization of safety behaviour as a maintaining factor of anxiety symptomatology 
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The effect of safety behaviour on the acceptability of exposure therapy  
for contamination fear 
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder, 
affecting approximately 1-2.5% of the population (APA, 2000). The disorder is 
heterogeneous in nature (Radomsky & Taylor, 2005), encompassing a wide variety of 
obsessions (i.e., intrusive thoughts, images, or impulses) and compulsions (i.e., behaviour 
aimed at preventing negative outcomes and/or decreasing anxiety). Among the most 
common symptoms of OCD are compulsive washing and contamination-related OCD 
(Rachman, 2004). For example, in a sample of 560 individuals with OCD, 50% had 
contamination fears (Rasmussen & Eisen, 1992). In addition to their prevalence, 
contamination fears are persistent and unrelenting. Once the threat of contamination has 
been realized, individuals may engage in compulsive washing until they achieve adequate 
cleanliness, which can be difficult to attain (Wahl, Salkovskis, & Cotter, 2008). 
 Due to its widespread and debilitating nature, it is important to develop effective 
treatments for contamination-related OCD. A controlled trial found that clients with 
compulsive cleaning rituals responded worse to treatment than did clients with other 
forms of OCD (Coelho & Whittal, 2001). Exposure and response prevention (ERP) is 
frequently used in evidence-based treatment for OCD (Cognitive-Behavioural Therapy, 
CBT). ERP for contamination fear involves repeatedly exposing the client to feared 
contaminants while preventing engagement in compulsive behaviour (e.g., washing), 
which gradually degrades the fear response to the contaminants (Meyer, 1966; Barlow, 
2002; Clark, 2004). While ERP is effective for OCD (e.g., Foa et al., 2005), too many 





exacerbation (Rachman, 2004). For example, in a randomized-controlled trial of ERP for 
OCD with and without clomipramine, Foa and colleagues (2005) reported that 14% of 
participants declined study participation altogether due to unwillingness to receive ERP, 
22% withdrew upon randomization into the ERP condition, and an additional 22% 
dropped out during ERP. Other randomized-controlled trials with similar designs have 
reported comparable rates of refusals and dropouts from CBT (e.g., Barlow, Gorman, 
Shear, & Woods, 2000). This means that a substantial proportion of clients do not receive 
effective treatment for their OCD.  
 How can ERP be modified to enhance its acceptability without detracting from its 
efficacy? Some suggest that the judicious use of safety behaviour, especially in the early 
stages of treatment when dropouts and refusals are most likely (Rachman, 2004), may be 
the answer (Parrish, Radomsky, & Dugas, 2008; Rachman, Radomsky, & Shafran, 2008). 
Safety behaviour is defined as overt or covert avoidance strategies carried out in feared 
situations to minimize perceived threat (Salkovskis, Clark, & Gelder, 1996). Within the 
context of contamination-related OCD, some examples of safety behaviour include overt 
behaviour such as washing or covert strategies such as avoiding eye contact with 
perceived contaminants. Many cognitive-behavioural theorists assert that safety 
behaviour interferes with exposure therapy such that it facilitates the avoidance of feared 
outcomes and leads to misattributions of safety in threatening situations (Salkovskis, 
1991). For example, individuals with panic disorder may carry safety aids like water 
bottles or cellular phones. By relying on these safety aids, these individuals may falsely 






 Several empirical studies have shown that safety behaviour indeed interferes with 
the benefits of exposure therapy (e.g., Salkovskis, Clark, Hackmann, Wells, & Gelder, 
1999; Kim, 2005; for a review, see Helbig-Lang & Petermann, 2010). Findings have 
generally shown that participants who are discouraged from using safety behaviour 
during exposure therapy fare significantly better than participants permitted to use it. For 
example, Olatunji, Etzel, Tomarken, Ciesielski, and Deacon (2011) found that 
participants who were instructed to engage in health-related safety behaviour (e.g., taking 
two or more showers daily) reported greater increases in health anxiety, hypochondriacal 
beliefs, contamination fear, and avoidance than participants who monitored their normal 
use of safety behaviour. Additionally, research suggests that even the perceived 
availability of safety behaviour may impact the benefits of exposure. Powers, Smits, and 
Telch (2004) randomized individuals with claustrophobia to exposure, exposure plus 
safety behaviour, and exposure plus the availability of safety behaviour (i.e., use it “only 
if you must”) and found that participants in the exposure condition reported less 
suffocation fears and more clinically-significant change at follow-up than participants in 
both safety behaviour conditions. However, it should be noted that a recent study failed to 
replicate these results (see Sy, Dixon, Lickel, Nelson, & Deacon, 2011). 
 Despite convincing evidence for the detrimental effects of safety behaviour on 
treatment outcome, some theorize that the judicious use of safety behaviour may actually 
enhance the benefits and acceptability of exposure therapy (Parrish et al., 2008; Rachman 
et al., 2008). There is growing empirical support for this claim, with recent studies 
suggesting that exposure with safety behaviour (ESB) is comparably effective to 





found that nonclinical participants who used safety behaviour (i.e., hygienic wipes) 
during exposures to a feared contaminant reported comparable if not greater reductions in 
contamination, fear, danger, and disgust as compared to participants who refrained from 
using safety behaviour. These findings have been replicated by an independent team of 
investigators in a subclinical sample (van den Hout, Engelhard, Toffolo, & van Uijen, 
2011). In another study, Milosevic and Radomsky (2008) compared exposure to a live 
snake with and without safety gear (e.g., gloves, goggles) and found that participants 
using safety gear approached the snake more rapidly and reported comparable fear 
reductions and cognitive change at post-treatment. A related study found that participants 
with spider phobia randomized to ESB reported similar reductions in subjective distress 
and negative beliefs about spiders compared to participants in the exposure-only 
condition (Hood, Antony, Koerner, & Monson, 2010).  
Of course, these findings are in direct opposition to current cognitive-behavioural 
conceptualizations of anxiety disorders. However, a closer look at the literature reveals 
that safety behaviour may not actually prevent the acquisition of threat-relevant 
information that ultimately leads to cognitive change. Earlier work by Rachman, Craske, 
Tallman, and Solymon (1986) compared the effects of exposure therapy and exposure 
plus instructions to escape the feared situation among individuals with agoraphobia. No 
group differences on any measures of agoraphobia were found, including perceived 
control and estimates of danger. Coupled with more recent findings demonstrating no 
differences between exposure therapy and ESB on measures of cognitive change 
(Milosevic & Radomsky, 2008; Hood et al., 2010), safety behaviour may benefit from 





necessary component of the acquisition of threat-relevant information during exposure 
(Mowrer, 1960). Because recent studies have shown that safety gear is associated with 
closer (Milosevic & Radomsky, 2012) and more rapid (Milosevic & Radomsky, 2008; 
Hood et al., 2010) approach to feared stimuli, it could be that safety behaviour actually 
facilitates essential learning processes during exposure therapy.  
 While controversial, the judicious use of safety behaviour in the early stages of 
exposure treatment may enhance its acceptability (Rachman et al., 2008). Of course, 
empirical research to support this claim is warranted (and is likely only meaningful if 
outcome research shows that the judicious use of safety behaviour does not negatively 
impact treatment effectiveness). Treatment acceptability has been described as the degree 
to which an individual perceives a treatment procedure to be fair, reasonable, appropriate, 
and un-intrusive for a given clinical problem (Kazdin, 1980; O’Brien & Karsh, 1991). 
For anxiety disorders, the literature suggests that cognitive-behavioural therapy (CBT) 
may be more acceptable than pharmacotherapy (Hofmann et al., 1998; Huppert, Franklin, 
and Foa, 2003). For example, in a sample of clinically anxious individuals, participants 
rated CBT as more acceptable than pharmacotherapy and more participants ranked CBT 
as their first choice even though a large percentage of the sample had a recent history of 
pharmacotherapy, not psychotherapy (Deacon & Abramowitz, 2005). Similarly, another 
study found that among 14 treatments available for PTSD, cognitive therapy, cognitive 
therapy with exposure, imaginal exposure, psychoeducation, and in vivo exposure were 
ranked the highest (all of which are elements of CBT; Tarrier, Liversidge, & Gregg, 





without safety behaviour, participants rated CBT with safety behaviour as more 
acceptable than CBT alone (Milosevic & Radomsky, 2012).  
 Taken together, the empirical evidence suggests that CBT may be the preferred 
treatment for a variety of anxiety disorders. If this is the case, why are so many clients 
refusing the treatment entirely or dropping out after a few sessions? Clearly more work is 
needed to improve the acceptability of CBT and exposure therapy. Using safety 
behaviour to enhance treatment acceptability is a sensible solution on a theoretical level; 
however, it must be empirically tested. To this end, the first goal of the current study was 
to assess the acceptability of exposure therapy for contamination fear with and without 
the use of safety behaviour. First, it was hypothesized that exposure with safety 
behaviour (ESB) would be rated as more acceptable than exposure and response 
prevention (ERP). It was further hypothesized that subjective fear ratings would be lower 
and behavioural approach to a series of contaminants would be greater in the ESB 
condition compared to the ERP condition.  
The second goal of the proposed study was to assess the acceptability of ESB and 
ERP among individuals with varying levels of contamination fear. Here, it was 
hypothesized that individuals reporting high levels of contamination fear would rate ESB 
as significantly more acceptable than ERP compared to individuals low on contamination 
fear. In other words, it was hypothesized that the difference in acceptability ratings 
between ESB and ERP would be predicted by level of contamination fear.  
Of course, before credible research can be conducted, valid and reliable measures 
that assess treatment acceptability and adherence are needed. There is a paucity of 





specifically about treatment adherence. Therefore, the third goal of the proposed study 
was to validate a measure called the Treatment Acceptability Scale (TXA; Milosevic & 
Radomsky, 2012), which assesses treatment acceptability and adherence. This measure 
was administered along with a published scale of treatment acceptability (the 
Endorsement and Discomfort Scale, EDS; Tarrier et al., 2006). Here, it was hypothesized 
that the TXA would have acceptable to excellent psychometric properties as assessed by 
Cronbach’s alpha, convergent validity with the EDS and the Credibility/Expectancy 
Questionnaire (CEQ; Devilly & Borkovec, 2000), and divergent validity with the State-
Trait Anger Expression Inventory-2 (STAXI-2; Spielberger, 1999). 
Method 
Participants 
Participants were 81 undergraduate students at Concordia University who 
participated in this study in exchange for course credit or entry into a draw for cash 
prizes. The only inclusion/exclusion criteria were ability to understand, read, and 
communicate in English and no prior cognitive-behavioural therapy (CBT). The majority 
of participants were female (84%) and ranged in age from 17 to 63 (M = 23.85, SD = 
7.72) years. Forty of the participants identified English as their first language (49%) and 
48 reported speaking English at home (59%), either as the only spoken language or in 
combination with other languages. All participants completed both treatment conditions 
(i.e., ESB and ERP). 
Measures 
Behavioural Approach Test (BAT). The BAT is a commonly used behavioural 





contaminants during each exposure session: one was moderately contaminated (i.e., dirty 
laundry, a dirt mixture; see Materials) and one was extremely contaminated (i.e., a dirty 
toilet, a dirty bedpan; see Materials). After each stimulus presentation and accompanied 
description (see Materials), participants were asked to approach the contaminant as close 
as they were able. The distance was coded on a 6-point hierarchy, ranging from 
approaching the contaminant and smelling it from within three feet to touching the 
contaminant and then rubbing hands together (see Appendix C for a detailed description 
of the BAT). This BAT has been used in research on compulsive washing (see Cougle, 
Wolitzy-Taylor, Lee, & Telch, 2007). The number of steps completed served as the 
measure of behavioural approach for each contaminant.  
Beck Anxiety Inventory (BAI; Beck & Steer, 1990) is a 21-item questionnaire that 
assesses general symptoms of anxiety. Participants are asked to rate the degree to which 
their anxious symptoms bother them on a 4-point Likert scale (0 = Not at all; 3 = 
Severely, I could barely stand it). The BAI has high internal consistency (α = .92) and 
test-retest reliability (r = .75) and shows high convergent and discriminant validity in 
clinical and non-clinical samples (Beck, Epstein, Brown, & Steer, 1988). The BAI 
showed excellent internal consistency in the current sample (α = .92). 
Contamination Rating. The contamination rating served as the manipulation 
check for this study. Participants were asked to rate the perceived level of contamination 
of each contaminant after completing the BAT for that particular contaminant. The 
contamination rating went as follows: “On a scale of 0-100, 0 being not at all 
contaminated and 100 being the most you can imagine, how contaminated is the object 





 Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000) is a 
6-item questionnaire that assesses perceived credibility and expectancy of a given 
treatment. The credibility items are rated on a 9-point Likert scale (1 = Not at all 
useful/logical; 9 = Very useful/logical), while the expectancy items are rated on an 11-
point percentage scale (0% - 100% improvement in symptoms). The authors reported 
adequate internal consistency (α = .84) and test-retest reliability (r = .83). The CEQ was 
administered with the TXA to assess convergent validity of the TXA. The CEQ showed 
adequate internal consistency in the current sample (α = .71 for ESB and α = .69 for 
ERP).  
Endorsement and Discomfort Scale (EDS; Tarrier et al., 2006) is a 10-item 
questionnaire developed for research on treatment acceptability. It assesses treatment 
preference and acceptability on a variety of dimensions, including suitability, tolerability, 
and reasonableness, among others. Participants are asked to rate the degree to which they 
agree with each of the statements about a given treatment on a 9-point Likert scale (1 = 
Disagree strongly; 9 = Agree strongly). The authors reported that the first 9 items of the 
EDS loaded onto a single factor they termed treatment “endorsement,” and the last item 
loaded onto a factor they conceptualized as treatment “discomfort.” The EDS was 
administered with the TXA to assess convergent validity of the TXA. The EDS showed 
excellent internal consistency in the current sample (α = .92 for ESB and α = .93 for 
ERP). 
OCD Treatment History Questionnaire (OC-THQ; Stobie, Taylor, Quigley, 
Ewing, & Salkovskis, 2007) is a 10-item questionnaire that assesses previous 





exposure) to verify previous cognitive-behavioural therapy (CBT). For the purposes of 
the current study, this questionnaire was adapted to make it more general (i.e., not 
exclusively for previous OCD treatment). To meet minimum criteria for previous CBT, 
the therapy had to be 6 or more sessions with at least 40 minutes per session and had to 
include exposure, homework, a focus on the problem and not on childhood, and a 
therapist who was not silent for most of the sessions. The authors reported that the OC-
THQ effectively discriminated individuals who had previously received CBT from those 
who had received other therapeutic interventions.  
State-Trait Anger Expression Inventory-2 (STAXI-2; Spielberger, 1999) is a 57-
item questionnaire that assesses the intensity of anger as an emotional state (State Anger) 
and as a personality trait (Trait Anger). For the purposes of the current study, only the 
State Anger subscale was administered along with the TXA for analyses of divergent 
validity. The State Anger subscale consists of 15 items and participants are asked to rate 
how angry they feel right now on a 4-point Likert scale (1 = Not at all; 4 = Very much 
so). The STAXI-2 has shown excellent convergent and divergent validity, as well as high 
internal consistency when administered in research contexts (α = .94; e.g., Patterson, 
Kerrin, Wileyto, & Lerman, 2008). The State Anger subscale showed adequate internal 
consistency in the current sample (α = .83 for ESB and α = .85 for ERP). 
Subjective Units of Distress Scale (SUDS; Wolpe, 1958) is a widely-used measure 
of subjective fear during behaviour therapy. For the current study, participants were 
asked to rate how fearful they felt on a scale from 0 to 100, 0 being neutral and 100 being 
the worst distress they can imagine. The SUDS was administered at four time points 





moderately and extremely contaminated; the Anticipatory SUDS rating) and while 
touching the contaminants (i.e., after reaching the last step in the BAT they could attain; 
the Peak SUDS rating).  
Treatment Acceptability Scale (TXA; Milosevic & Radomsky, 2012) is a 10-item 
questionnaire designed to assess treatment acceptability on a variety of dimensions, 
including adherence, perceived intrusiveness, and tolerability, among others. Items are 
rated on a 7-point Likert-type scale (1 = Disagree strongly; 7 = Agree strongly) to assess 
if participants agree with a variety of statements about the treatment about which they 
have just read a descriptive vignette. For the purposes of the current study, the TXA was 
administered along with the EDS to assess the psychometric properties of the TXA, but 
the descriptive vignettes were not provided. Rather, participants were asked to respond to 
each item with regards to the exposure session in which they had just engaged (i.e., ESB 
or ERP). The authors have reported excellent internal consistency for the TXA (α = .87; 
Milosevic & Radomsky, 2010). The TXA showed excellent internal consistency in the 
current sample (α = .88 for ESB and α = .86 for ERP). 
Vancouver Obsessional Compulsive Inventory (VOCI; Thordarson et al., 2004) is 
a 55-item questionnaire that assesses a variety of OCD symptoms, including 
contamination fear. Participants are asked to rate the degree to which the statements are 
true of them on a 5-point Likert scale (0 = Not at all; 4 = Very much). The VOCI has 
shown excellent internal consistency in student (α = .96) and clinical samples (α = .94), 
as well as convergent and divergent validity (Radomsky et al., 2006; Thordarson et al., 





VOCI was administered, and it demonstrated excellent internal consistency in the current 
sample (α = .91). 
Materials 
 Bedpan. A bedpan filled with dilute apple juice was used as one of the 
extremely contaminated objects. When presented with the bedpan, participants were told, 
“This is a dirty bedpan.” The apple juice was diluted to decrease the juice’s smell, and 
one spray of all-purpose cleaner was added to eliminate any residual odor. This stimulus 
has been used in previous research on contamination-related OCD (see Olatunji, Lohr, 
Sawchuck, & Tolin, 2007).   
 Dirt mixture. A mixture of potting soil, dead crickets, and cat hair was placed 
in a shallow plastic box and used as one of the moderately contaminated objects. When 
presented with the dirt mixture, participants were told, “This is a mixture of dirt, dead 
insects, and animal hair.” This stimulus has been used in previous research on 
compulsive washing (see Cougle et al., 2007). 
 Dirty laundry. A pile of dirty underwear, socks, t-shirts, and rags was placed in 
a laundry basket and used as one of the moderately contaminated objects. When 
presented with the laundry, participants were told, “This is a box of dirty laundry. It 
includes socks, underwear, old t-shirts, and rags. Some of these items may have been 
touched with bodily fluids.” This stimulus has been used in previous research on 
compulsive washing (see Cougle et al., 2007).  
 Toilet. A porcelain toilet was smeared with potting soil and chocolate and used 





were told, “This is a dirty toilet.” This stimulus has been used in previous research on 
compulsive washing (see Cougle et al., 2007). 
 Safety gear. If completing the ESB session, participants were offered a pair of 
latex-free rubber gloves before they began the BAT.  
Procedure 
 Participants were told they were participating in a study evaluating two 
versions of an existing treatment for contamination fear. Following the informed consent 
process, participants began their first exposure session, either with or without safety gear. 
The order in which the participants engaged in each condition was counterbalanced, so 
that an equal number of participants began with exposure with safety behaviour (ESB) as 
exposure and response prevention (ERP). The contaminants were also counterbalanced, 
so that an equal number of participants began with the dirty laundry as the dirt mixture 
and the bedpan as the toilet. Before beginning the first BAT, the experimenter presented 
the first object (moderately contaminated; either dirty laundry or a dirt mixture) and 
provided a description for it (see Materials). If this was an ESB session, participants were 
offered a pair of latex-free rubber gloves (right after they heard the object’s description) 
to wear while approaching the contaminant. To avoid implying the absolute necessity of 
safety gear, the gloves were offered as follows: “Here is a pair of latex-free gloves that 
might be helpful to you while approaching the [name of contaminant].” Participants were 
then asked to provide their Anticipatory SUDS rating. Following the Anticipatory SUDS 
rating, the BAT was introduced as follows: “Now I will ask you to approach this 
contaminant in a stepwise fashion. The first step is...” (see Appendix C for detailed 





reached the last step they could attain. Participants then provided the contamination 
rating as a manipulation check.  
 If this was an ESB session, participants were told to leave their gloves on for 
the next BAT. The same procedure then ensued with the extremely contaminated object 
(dirty toilet or dirty bedpan) once the participants were provided with the object’s 
description and indicated their Anticipatory SUDS rating. Once the participants reached 
the last step in the BAT they could attain, they provided their Peak SUDS rating and the 
contamination rating. Following exposure to the second object, participants completed 
the EDS, TXA, CEQ, and STAXI-2. 
 Following completion of these measures, participants began the second 
exposure session, again with or without safety gear. The experimenter presented the first 
contaminant (moderately contaminated; whichever object was not used during the first 
exposure session) and provided a description for it. If this was an ESB session, the 
participant was offered a pair of latex-free rubber gloves to wear while approaching the 
contaminant. The participant then provided their Anticipatory SUDS rating and began 
approaching the contaminant. Once they reached the last step in the BAT they could 
attain, they provided their Peak SUDS rating and the contamination rating.  
 If this was an ESB session, participants were asked to leave their gloves on for 
the next BAT. The same procedure then ensued for the extremely contaminated object 
(whichever one was not used during the first exposure session) once the experimenter 
provided a description of the object and obtained the Anticipatory SUDS rating. Once the 





SUDS and contamination ratings. Following exposure to the second object, participants 
again completed the EDS, TXA, CEQ, and STAXI-2. 
 Lastly, participants completed a questionnaire package which included the 
BAI, the contamination subscale of the VOCI, a demographics questionnaire, and a 
revised version of the OC-THQ. Following completion of the questionnaire battery, 
participants were fully debriefed.   
Results 
Data Screening 
 All data were collected on an online survey site that prevented participants from 
moving forward with additional survey items before completing all the previous items. 
For this reason, there were no missing data points or data entry errors.  
 Data screening procedures were carried out as recommended by Kline (2009). 
First, data were checked for out-of-range values (outliers). Individual scores were 
converted to Z-scores based on mean values, and these Z-scores were inspected for 
values exceeding +/- 3 (i.e., 3 standard deviations above or below the mean; Kline, 2009). 
This procedure revealed several outliers, so these values were re-entered as the next-
lowest or next-highest score which did not exceed +/- 3 standard deviations. Next, 
indexes of skew and kurtosis were calculated for each of the dependent variables, which 
revealed one skewed variable. The number of BAT steps completed for the moderately 
contaminated object in ESB had a skew index of -5.00 and a kurtosis index of 23.54, 
indicating negative skew (i.e., most participants completed all 6 steps of this BAT). 
Given the relevancy of this result to the current study’s hypotheses, it was decided not to 
apply a transformation method to this variable other than the replacement of outliers 






Only one participant met criteria for previous cognitive-behavioural therapy 
(CBT), as assessed by a revised version of the OC-THQ (Stobie et al., 2007; see 
Measures). This participant was excluded from the analyses that follow. 
Manipulation Check 
 The toilet had the highest contamination rating (M = 71.34, SD = 28.80), followed 
by the bedpan (M = 67.81, SD = 31.42), the dirt mixture (M = 52.74, SD = 30.67), and the 
laundry (M = 48.45, SD = 28.73). The extremely contaminated objects were rated as 
significantly more contaminated than the moderately contaminated objects (all t’s > 4.47, 
all p’s < .001). Ten participants (13%) provided a contamination rating of 0 (i.e., not at 
all contaminated) for at least one contaminant. Of these 0 contamination ratings, five 
(33%) were for the dirt mixture, four (27%) were for the bedpan, three (20%) were for 
the laundry, and three (20%) were for the toilet. These 10 participants were excluded 
from the analyses that follow, leaving a final sample of 70 participants.   
Treatment Acceptability 
 To assess the acceptability of each treatment condition (i.e., ESB and ERP), a 
one-way repeated-measures analysis of variance (ANOVA) was conducted. There was a 
significant difference in EDS scores, F(1, 69) = 7.22, p = .009, η2 = .10, such that the 
ESB condition was rated as significantly more acceptable than the ERP condition (see 










Means and Standard Deviations of Dependent Measures 
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Exposure with safety 
behaviour (ESB) 











Subjective fear (Moderately) 
      









      








Subjective fear (Extremely) 
      







     










Behavioural approach  
      







      







Note. N = 70. Moderately = Moderately contaminated object. Extremely = Extremely 
contaminated object. SUDS = Subjective Units of Distress Scale. Adjacent means are 
significantly different from each other.  
*p < .01. **p < .001. 
 
Subjective Fear  
 To assess subjective fear in each treatment condition (i.e., ESB and ERP), two 2 
(condition) x 2 (stimulus type) x 4 (time) repeated-measures ANOVAs were conducted, 





a significant difference in Anticipatory SUDS ratings by condition, F(1, 69) = 20.05, p < 
.001, partial η2 = .23, and by stimulus type, F(1, 69) = 43.15, p < .001, partial η2 = .39, 
such that Anticipatory SUDS ratings were significantly lower in the ESB condition 
compared to the ERP condition for both the moderately and extremely contaminated 
objects (see Table 1 above). There was no interaction, F(1, 69) = .12, p = .73.  
There was a significant difference in Peak SUDS ratings by condition, F(1, 69) = 
38.30, p < .001, partial η2 = .36, and by stimulus type, F(1, 69) = 80.51, p < .001, partial 
η2 = .54, such that Peak SUDS ratings were significantly lower in the ESB condition 
compared to the ERP condition for both the moderately and extremely contaminated 
objects (see Table 1 above). There was no interaction, F(1, 69) = .83, p = .37.  
 Behavioural Approach 
 To assess behavioural approach in each treatment condition (i.e., ESB and ERP), 
a 2 (condition) by 2 (stimulus type) by 4 (time) repeated-measures ANOVA was 
conducted. There was a significant difference in behavioural approach by condition, F(1, 
69) = 28.49, p < .001, partial η2 = .29, and by stimulus type, F(1, 69) = 27.84, p < .001, 
partial η2 = .29, such that the number of BAT steps completed was significantly higher in 
the ESB condition compared to the ERP condition for both the moderately and extremely 
contaminated objects (see Table 1 above). There was also an interaction between 
condition and stimulus type, F(1, 69) = 4.90, p = .03, partial η2 = .07, such that the effect 
of condition was greater for the extremely contaminated objects than for the moderately 






Figure 1. Mean number of BAT steps completed. N = 70. BAT = Behavioural approach 
test. ESB = Exposure with safety behaviour. ERP = Exposure and response prevention. 
Moderately = Moderately contaminated object. Extremely = Extremely contaminated 
object. Error bars represent standard errors. 
 
Contamination Scores and Treatment Acceptability 
 Scores on the contamination subscale of the VOCI ranged from 3 to 41 (M = 
14.19, SD = 8.67). To assess the predictive utility of contamination scores on treatment 
acceptability, a simple linear regression was conducted. Scores on the contamination 
subscale of the VOCI were entered as the independent variable and the difference in EDS 
scores between ESB and ERP was entered as the dependent variable. Contamination 
scores did not predict the difference in acceptability ratings between ESB and ERP (β = -































Validation of the Treatment Acceptability Scale (TXA) 
 Two participants (3%) were excluded from the analyses that follow as they did 
not complete the CEQ, leaving a final sample of 68 participants for the validation study. 
To assess internal consistency of the TXA, Cronbach’s alpha was calculated for 
both administrations of the TXA (i.e., after ESB and after ERP) which revealed excellent 
internal consistency (α = .88 for ESB and α = .86 for ERP).  
To assess convergent validity of the TXA, Pearson correlations were employed. 
There was a significant positive correlation between the TXA and the EDS and between 
the TXA and the CEQ for both administrations of these measures (i.e., after ESB and 
after ERP; see Table 2 below).  
To assess divergent validity of the TXA, Pearson correlations were employed. 
There was a significant negative correlation between the TXA and the STAXI-2 (see 







Correlations between Treatment Acceptability, Endorsement and Discomfort, 
Credibility/Expectancy, and State Anger 
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Note. N = 68. TXA = Treatment Acceptability Scale. EDS = Endorsement and 
Discomfort Scale. CEQ = Credibility/Expectancy Questionnaire. STAXI = State Anger 
Expression Inventory-2.  
*p < .05. **p < .01. ***p < .001. 
 
To compare the magnitude of the correlations between the TXA and EDS 
(convergent measures) and the TXA and STAXI-2 (divergent measures) for both 
administrations of these measures, two t-tests for dependent correlations were employed, 
the first for the administration following ESB and the second for the administration 
following ERP. These analyses revealed significant differences in the correlations, such 
that the correlations between the TXA and EDS were higher in magnitude than the 
correlations between the TXA and STAXI-2 (t = 10.81, p < .01 for ESB and t = 9.81, p < 





Finally, partial Pearson correlations were conducted between the TXA and EDS, 
controlling for scores on the BAI. These analyses revealed that the associations between 
the TXA and EDS were not due to general symptoms of anxiety for either administration 
of these measures (r = .77, p < .001 for ESB and r = .78, p < .001 for ERP).  
Discussion 
 It has been proposed that safety behaviour may enhance the acceptability of 
exposure therapy (Rachman et al., 2008), an evidence-based treatment for anxiety 
disorders that is prone to dropouts and refusals. The current study tested this proposal by 
comparing the acceptability of exposure with safety behaviour (ESB) and exposure and 
response prevention (ERP) for contamination fear. Overall, the results of this study 
indicate that ESB is more acceptable than ERP. These findings support the notion that 
safety behaviour may be used to increase the acceptability of exposure-based treatments.  
Safety Behaviour and Treatment Acceptability 
 It was predicted that ESB would be rated as more acceptable than ERP. This 
hypothesis was supported, as the acceptability rating of the ESB condition was 
significantly higher than that of the ERP condition. Additionally, condition (i.e., ESB or 
ERP) explained 10% of the total variance in acceptability scores, lending further support 
for this hypothesis.  
 In addition to self-reported acceptability, we hypothesized that subjective fear 
ratings would be lower in ESB compared to ERP. This hypothesis was supported, as both 
Anticipatory and Peak SUDS ratings were significantly lower in the ESB condition 
compared to the ERP condition for both the moderately and extremely contaminated 





variance in Anticipatory SUDS ratings and 36% of the residual variance in Peak SUDS 
ratings, further supporting this hypothesis.  
We also predicted that behavioural approach to the contaminants would be greater 
in ESB compared to ERP as measured by a series of behavioural approach tests (BATs). 
This hypothesis was supported, as participants completed significantly more steps in the 
BATs during the ESB condition than during the ERP condition. Condition (i.e., ESB or 
ERP) explained 29% of the residual variance in behavioural approach. Interestingly, there 
was an interaction between condition and stimulus type (i.e., moderately or extremely 
contaminated object), such that the effect of condition was greater for the extremely 
contaminated objects. This is a noteworthy finding, as it suggests that safety behaviour 
may be particularly helpful during exposure to highly distressing situations or objects. 
Given that dropouts typically occur in the beginning stages of treatment when exposure 
may seem especially threatening or unacceptable (Rachman, 2004), perhaps safety 
behaviour should be implemented for the most difficult exposure sessions to prevent 
withdrawal from treatment.  
Taken together, these findings support the notion that safety behaviour enhances 
the acceptability of exposure therapy. Given that a substantial proportion of clients drop 
out of CBT (Hofmann et al., 1998), in particular ERP for OCD (Foa et al., 2005), 
modification of the treatment is critically needed. As demonstrated by the current study’s 
results, exposure with safety behaviour may be a promising approach to increasing 
treatment acceptability. In addition to self-reported acceptability, participants in this 
study reported lower levels of anxiety and were able to approach the contaminants more 





stimulus is sometimes necessary for disconfirmation of threat-relevant beliefs to occur, it 
is encouraging that safety behaviour may actually facilitate behavioural approach during 
exposure. These results are consistent with previous research documenting closer 
approach to feared stimuli during exposure sessions with safety gear (Milosevic & 
Radomsky, 2008, 2012), as well as recent evidence demonstrating substantial reductions 
in fear and avoidance following exposure with safety behaviour (Rachman et al., 2011; 
van den Hout et al., 2011). Although treatment outcome was not a primary focus of the 
current study, overall it appears that safety behaviour may not necessarily interfere with 
CBT. Therefore, the unqualified rejection of safety behaviour during exposure therapy 
may be unnecessary at this time (Rachman et al., 2008). 
More specifically, the judicious use of safety behaviour in exposure therapy may 
be beneficial. Judicious use has been defined as “the careful use of safety behaviour, with 
an emphasis on the early stages of treatment” (Rachman et al., 2008, p. 169). In practice, 
this might consist of introducing safety behaviour in the first few exposure sessions until 
the client feels comfortable to eliminate it, or implementing safety aids for especially 
difficult exposures. As mentioned previously, the results of this study indicate that safety 
gear may be particularly helpful during exposure to highly distressing situations or 
objects. Additionally, clients could be trained to seek safety rather than distance 
themselves from it, providing enhanced sense of control and mastery over exposure 
sessions (Rachman et al., 2008). While the results of this study suggest that safety 
behaviour enhances the acceptability of single-session exposure therapy, the impact of a 






The mechanism underlying the effect of safety behaviour in exposure therapy is 
unclear. Some suggest that reliance on safety behaviour maintains anxiety and avoidance 
(Salkovskis, 1991), while others argue that safety behaviour may be beneficial by 
increasing self-efficacy and control during exposure, thus facilitating adaptive coping 
strategies (Parrish et al., 2008; Rachman et al., 2008). Consistent with the latter theory, 
recent studies have shown that participants who used safety gear during exposure 
reported increased self-efficacy and confidence to cope with threatening situations (Hood 
et al., 2010; Milosevic & Radomsky, 2012). In the current study, precautions were taken 
not to imply that safety gear was necessary to complete the exposure sessions (i.e., 
“reliance” on safety behaviour), but rather might be helpful to participants. If safety 
behaviour is offered in such a way, participants may feel some control over the exposure 
sessions, thus promoting self-efficacy and self-confidence. Several participants in this 
study made comments that suggested they felt more comfortable and more in-control 
while completing the ESB condition (e.g., “I would not do this without gloves” or “With 
gloves on? I’m fine”). These comments were generally absent or reversed in the ERP 
condition (e.g., “I feel like my hands are all dirty” or “I want to throw up”). Based on 
these results and recent empirical investigations, it could be that enhanced self-efficacy 
may be a key mechanism underlying the impact of safety behaviour in exposure therapy. 
Of course, this is an empirical question. 
Contamination Fear and Treatment Acceptability 
Although the main focus of this study was to compare the acceptability of ESB 
and ERP, we were also interested in the association between contamination fear and 





difference in acceptability ratings between ESB and ERP. This hypothesis was not 
supported. In fact, scores on the VOCI contamination subscale were virtually unrelated to 
the difference in acceptability ratings between the two treatment conditions. This was an 
unexpected result for several reasons. First, Rachman et al. (2008) have proposed the 
judicious use of safety behaviour for severely distressed or fearful clients that may find 
exposure particularly unacceptable. Second, Rachman and colleagues (2011) recently 
introduced safety behaviour for severe cases of contamination-related OCD that were 
unresponsive to or unwilling to receive ERP. Given the nature of the current sample (i.e., 
undergraduate students rather than individuals with clinically-significant contamination 
fear), it is likely that a restricted range in contamination scores affected these results. 
Alternatively, it could be that severity of contamination fear is indeed unrelated to 
treatment acceptability, in which case the use of safety behaviour may be beneficial 
regardless of symptom profile. Previous research investigating the association between 
OCD symptom severity and dropout from CBT has yielded mixed findings, with some 
authors reporting no association (Rector, Cassin, & Richter, 2009) and others finding 
higher symptom levels only among early drop-outs (i.e., before session 6; Aderka et al., 
2011). Future research is needed to clarify the relationship between symptoms of anxiety 
and treatment preference, particularly among clinical populations.  
Treatment Acceptability Scale (TXA) 
 The last objective of this study was to validate a new measure of treatment 
acceptability and adherence called the Treatment Acceptability Scale (TXA). It was 
hypothesized that the TXA would show acceptable to excellent psychometric properties. 





administrations of the TXA (i.e., after ESB and after ERP). The TXA also demonstrated 
convergent validity, as it was highly correlated with the EDS and CEQ, two related 
measures of treatment acceptability and credibility, respectively. Somewhat 
unexpectedly, the TXA was moderately negatively correlated with the STAXI-2 for both 
administrations of these measures, but the magnitude of these correlations was 
significantly lower than the correlations between the TXA and EDS. This provides 
evidence for divergent validity of the TXA. Furthermore, the relationship between the 
TXA and EDS could not be explained by general symptoms of anxiety, as this 
relationship remained significant after controlling for scores on the BAI. Given the 
paucity of self-report questionnaires available to assess treatment acceptability and 
adherence, these are encouraging preliminary findings for the reliability and validity of 
the TXA.  
Limitations and Future Directions 
 This study aimed to investigate the acceptability of exposure with safety 
behaviour (ESB), a novel alternate approach to traditional exposure and response 
prevention (ERP) for OCD. While the results are promising, the current study is not 
without its limitations. First, this study used a non-clinical sample of undergraduate 
students, limiting the generalizeability of the results to treatment-seeking clinical 
populations with contamination-related OCD or other anxiety problems. As suggested 
previously, future research should aim to replicate and extend these findings with 
clinically-anxious participants. Second, treatment acceptability was measured only once 
for each treatment session, which included two contaminants. This may call into question 





recall or did not consider the details of each behavioural approach when completing the 
EDS. We attempted to counteract this limitation by counterbalancing the contaminants, 
but we cannot verify whether participants equally considered all four BATs when 
providing their acceptability ratings. Future studies should measure acceptability 
following each behavioural approach to ensure adequate consideration of each one.  
 An additional limitation is the absence of a no-exposure control condition in this 
study. Although the aim of the current study was to compare the acceptability of ESB and 
ERP, a control condition would have been useful to verify that the main effect of 
condition was not due to a ceiling effect (both conditions were highly acceptable). A 
control condition would have allowed an additional basis of comparison, thus 
counteracting the potential ceiling effect. Future research should aim to replicate these 
findings using a no-exposure control condition. 
Finally, the use of covert safety behaviour (e.g., mentally reciting a comforting 
mantra) was not systematically controlled in this study. Therefore, it is possible that 
participants relied on covert safety aids to complete the exposures, potentially increasing 
the acceptability of the treatments. However, it is presumable that the use of a completely 
within-participants repeated-measures design controlled for the use of covert safety 
behaviour during the treatment sessions. A related limitation is the use of one safety aid 
in the ESB condition (i.e., latex-free gloves) rather than allowing participants to choose 
their own safety gear, as previous investigations have done (Milosevic & Radomsky, 
2008). Given that safety behaviour is highly idiosyncratic (Salkovskis et al., 1996), it is 
possible that some participants did not find the gloves particularly helpful during 





behaviour and/or encourage participants not to use it during the treatment sessions. 
Additionally, offering participants a selection of safety gear from which to choose would 
maximize the perceived helpfulness of safety behaviour.  
There are several possible future directions for this research. It will be helpful to 
elucidate the mechanisms underlying the impact of safety behaviour in exposure therapy. 
To date, these mechanisms are largely unexplored. To this end, increased self-efficacy 
may be an important potential mechanism to investigate in future research. It will also be 
necessary to evaluate whether the judicious use of safety behaviour indeed enhances 
treatment acceptability, particularly among clinical populations of individuals with 
anxiety disorders. The use of a clinical sample in future studies will also allow 
elucidation of the association between severity of anxiety symptoms and treatment 
preference. Given the unacceptably high rate of dropout from CBT for anxiety disorders, 
it is important to clarify potential risk factors for attrition. Finally, it will be useful to 
conduct additional psychometric studies of the TXA to support its reliability and validity, 






The current study demonstrated that exposure with safety behaviour (ESB) is 
more acceptable than exposure and response prevention (ERP) for contamination fear. 
These results support the notion that safety behaviour may enhance the acceptability of 
exposure therapy for anxiety disorders, a difficult and demanding treatment that is prone 
to dropouts and refusals. Although the current study did not focus specifically on 
treatment efficacy, previous research has demonstrated that safety behaviour does not 
necessarily interfere with the benefits of exposure therapy. Coupled with the current 
study’s results, safety behaviour may be a promising approach to increasing the 
acceptability of exposure-based treatments. Further replication and extension of these 
results is necessary to elucidate the mechanism underlying the impact of safety behaviour 
in exposure therapy, particularly among clinical populations. However, the current study 
provides a foundation for the acceptability-enhancing role of safety behaviour in 
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Beck Anxiety Inventory 
Credibility/Expectancy Questionnaire 
Endorsement and Discomfort Scale 
Revised version of the OCD Treatment History Questionnaire 
State-Trait Anger Expression Inventory-2 – State Anger Subscale 
 Treatment Acceptability Scale  








Below is a list of common symptoms of anxiety. Please read each item in the list 
carefully. Indicate how much you have been bothered by each symptom during the PAST 
WEEK, INCLUDING TODAY by placing an X in the corresponding space in the column 
















It was very 
unpleasant 







1 Numbness or tingling     
2 Feeling hot     
3 Wobbliness in legs     
4 Unable to relax     
5 Fear of worst happening     
6 Dizzy or lightheaded     
7 Heart pounding or racing     
8 Unsteady     
9 Terrified     
10 Nervous     
11 Feelings of choking     
12 Hands trembling     
13 Shaky     
14 Fear of losing control     
15 Difficulty breathing     
16 Fear of dying     
17 Scared     
18 Indigestion or discomfort in abdomen     
19 Faint     
20 Face flushed     









Please take a moment to consider the treatment you have just completed. Please respond 
to the questions below based on their respective scales.  
 
1. How logical does the treatment offered to you seem? 
 
Not at all logical            Somewhat logical    Very logical 
  1 2 3 4 5 6 7 8 9 
 
2. How successful do you think this treatment will be in reducing your symptoms? 
 
Not at all useful            Somewhat useful    Very useful 
1 2 3 4 5 6 7 8 9 
 
3. How confident would you be in recommending this treatment to a friend who 
experiences similar problems? 
 
Not at all confident            Somewhat confident    Very confident 
1 2 3 4 5 6 7 8 9 
 
4. How much improvement in your symptoms do you think will occur? 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
5. How much do you really feel that treatment will help you to reduce your 
symptoms? 
 
    Not at all                            Somewhat         Very much 
1 2 3 4 5 6 7 8 9 
 
6. How much improvement in your symptoms do you really feel will occur? 
 









Thinking about the treatment you have just completed, please evaluate your response to 
the treatment descriptions below. Select the number that best describes your 
agreement/disagreement with each statement. 
 
1. I would accept this treatment for reducing my fear/anxiety. 
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 
       Agree 
strongly 
 
2. This treatment is suitable for reducing my fear/anxiety.  
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 
       Agree 
strongly 
 
3. If I were to receive this treatment, it would be tolerable to me. 
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 
       Agree 
strongly 
 
4. I expect positive benefits if I participate in this treatment.  
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 
       Agree 
strongly 
 
5. This treatment is a credible option for my type of problem.  
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 
       Agree 
strongly 
 
6. This treatment should prove effective in reducing my fear/anxiety.  
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 











7. This treatment is appropriate for reducing my fear/anxiety. 
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 
       Agree 
strongly 
 
8. The requirements of this treatment are reasonable. 
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 
       Agree 
strongly 
 
9. This treatment is justifiable for application with individuals who are suffering from 
fear/anxiety.  
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 
       Agree 
strongly 
 
10. Participating in this treatment would cause me discomfort.  
 
1 2 3 4 5 6 7 8 9 
Disagree 
strongly 









Revised version of the OCD Treatment History Questionnaire 
 
1. Have you ever had psychotherapy?  
 YES   NO 
 
If you answered NO, please skip the remainder of this section. 
 





2. Who did you see? If you’ve been in psychotherapy more than once, please respond 








Nurse therapist __________ 
 




Family Therapist _________ 
 
Other (please specify) __________________________ 
 
Not sure _____________ 
 
 
3. Was this person a Cognitive Behaviour Therapist?   
 YES    NO    UNSURE 
 
4. How many sessions did you see them (approximately)? 
_______________ sessions 
 
5. How long in minutes did each session last? 
____________________ minutes 
 







7. What type of therapy was done? Check one. 
 
Supportive Therapy _____________ 
 
Behaviour Therapy _____________ 
 
Cognitive Behaviour Therapy ____________ 
 
Psychodynamic Therapy _____________ 
 
Group Therapy ___________ 
 
Family / couples therapy ___________ 
 
Other (please state) _________________________________________ 
 
Not sure _____________________ 
 
8. Did you do or your therapist do any of the following in therapy? Please circle yes/no. 
 
Spent most of the sessions talking about my childhood / past experiences YES   NO 
 
Deliberately expose yourself to frightening thoughts or things in the therapist’s office  
YES   NO 
 
Go into situations outside the therapy room where you had to face whatever you were 
afraid of on your own      YES   NO 
 
My therapist seemed to imply that the origins of my problem lie in my childhood, and the 
past should be explored in order to understand the present better YES    NO 
 
Looking at links between beliefs, thoughts and feelings YES    NO 
 
Go into situations outside the therapy room where you had to face whatever you were 
afraid of with your therapist present      YES    NO 
 
Concentrated on beliefs about thoughts most sessions YES    NO 
 
The therapist was silent for most of the sessions and allowed me to talk freely about 
whatever was on my mind at the time YES    NO 
 
Be given or do set reading on the problem YES    NO 
 







The therapy emphasized changing behaviour rather than working directly on thoughts 
YES    NO 
 
Changing the meaning attached to thoughts  YES    NO 
 








A number of statements that people use to describe themselves are given below. Read 
each statement and then circle the appropriate number on the rating sheet to indicate how 
you feel right now. There are no right or wrong answers. Do not spend too much time on 
any one statement. Mark the answer that best describes your present feelings. 
 
Fill in 1 for Not at all   
Fill in 2 for Somewhat     
Fill in 3 for Moderately so            
Fill in 4 for Very much so 
 
 
How I Feel Right Now 
 
1. I am furious     1 2 3 4 
2. I feel irritated     1 2 3 4 
3. I feel angry     1 2 3 4 
4. I feel like yelling at somebody  1 2 3 4 
5. I feel like breaking things   1 2 3 4 
6. I am mad     1 2 3 4 
7. I feel like banging on the table  1 2 3 4  
8. I feel like hitting someone   1 2 3 4 
9. I feel like swearing    1 2 3 4 
10. I feel annoyed     1 2 3 4 
11. I feel like kicking somebody   1 2 3 4 
12. I feel like cursing out loud   1 2 3 4 
13. I feel like screaming    1 2 3 4 
14. I feel like pounding somebody  1 2 3 4 









Please respond to the treatment that you just completed by indicating your agreement 
with each of the below statements.  
 
1.  If I began this treatment, I would be able to complete it. 
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 
  Agree 
strongly 
 
2.  If I participated in this treatment, I would be able to adhere to its requirements.  
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 
  Agree 
strongly 
 
3.  I would find this treatment exhausting. 
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 
  Agree 
strongly 
 
4.  It would be distressing to me to participate in this treatment.  
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 
  Agree 
strongly 
 
5.  Overall, I would find this treatment intrusive.  
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 
  Agree 
strongly 
 
6.  This treatment would provide effective ways to help me cope with my fear/anxiety. 
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 







7.  I would prefer to try another type of psychological treatment instead of this one.  
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 
  Agree 
strongly 
 
8. I would prefer to receive medication for my fear/anxiety instead of this treatment.  
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 
  Agree 
strongly 
 
9.  I would recommend this treatment to a friend with a similar problem (i.e. 
fear/anxiety). 
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 
  Agree 
strongly 
 
10.  If I began this treatment, I would likely drop out.  
 
1 2 3 4 5 6 7 
Disagree 
strongly 
  Neither 
agree nor 
disagree 










Please rate each statement by putting a circle around the number that best describes how 
much the statement is true of you. Please answer every item, without spending too much 
time on any particular item.  
 
How much is each of the following statements true of you?  
 
0 = Not at all 
1 = A little 
2 = Some 
3 = Much 
4 = Very much 
 
1. I feel very dirty after touching money 
 
2. I use an excessive amount of  disinfectants to keep my home or myself safe from 
germs 
 
3. I spend far too much time washing my hands 
 
4. Touching the bottom of my shoes makes me very anxious 
 
5. I find it very difficult to touch garbage or garbage bins 
 
6. I am excessively concerned about germs and disease 
 
7. I avoid using public telephones because of possible contamination 
 
8. I feel very contaminated if I touch an animal  
 
9. I am very afraid of having even slight contact with bodily secretions (blood, urine, 
sweat, etc.) 
 
10. One of my major problems is that I am excessively concerned about cleanliness 
 
11. I often experience upsetting and unwanted thoughts about illness 
 



















Session 1: ESB   ERP 
Moderately contaminated object: 
How likely to touch ________________ 
Anticipatory SUDS ________________ 
BAT steps completed ________________ 




Contamination rating ______________ 
Disgust rating ________________ 
 
Asked to wash hands _________________ 
 
Extremely contaminated object: 
 
How likely to touch ________________ 
Anticipatory SUDS ________________ 
BAT steps completed ________________ 




Contamination rating ________________ 
Disgust rating _________________ 
Asked to wash hands _________________ 






Session 2: ESB   ERP 
Moderately contaminated object: 
How likely to touch ________________ 
Anticipatory SUDS ________________ 
BAT steps completed ________________ 




Contamination rating ________________ 
Disgust rating _______________ 
Asked to wash hands _________________ 
 
 
Extremely contaminated object: 
 
How likely to touch ________________ 
 
Anticipatory SUDS ________________ 
 
BAT steps completed ________________ 
 






Contamination rating _____________ 
Disgust rating _______________ 
Asked to wash hands _________________ 














Behavioural Approach Test (BAT) 
 
Step 1  Approach contaminant and smell from within 3 ft. 
Step 2  Touch contaminant with a sheet of tissue 
Step 3  Touch contaminant with right index finger 
Step 4  Touch contaminant with right hand 
Step 5  Touch contaminant with both hands 
Step 6  Touch contaminant with both hands, then rub hands together 
 








Informed Consent Forms: 
 
 
First Consent Form 























CONSENT FORM TO PARTICIPATE IN RESEARCH 
 
This is to state that I agree to participate in a program of research being conducted by 
Hannah Levy (ha_levy@live.concordia.ca; 514-848-2424 ext 5965) under the 
supervision of Dr. Adam Radomsky (adam.radomsky@concordia.ca; 514-848-2424 ext 
2202) in the Psychology Department of Concordia University. 
 
A. PURPOSE 
I have been informed that the purpose of this study is to evaluate different components of 
treatment for contamination fear. Contamination fear is intense fear of objects that are 
perceived as dirty, disgusting, or illness-causing. Individuals with contamination fear 
experience severe anxiety and distress when confronted with these objects. 
 
B. PROCEDURES 
If I agree to participate in this study, I will be asked to approach a variety of 
contaminants, as close as I am able, and then provide my anxiety rating. After 
approaching these contaminants, I will complete three questionnaires that evaluate the 
treatment sessions I have just completed. I will then be asked to complete a questionnaire 
package. The package should take approximately 40 minutes to complete. These 
questionnaires ask no questions regarding my name and they will not be connected in any 
way with my contact details. Finally, I will be fully debriefed about the purpose of the 
study as well as the hypotheses. For my participation, I will receive the opportunity to 
submit my name in a draw for cash prizes, OR course credit if I am part of the 
undergraduate participant pool at Concordia University. I am aware that this study 
employs a standardized protocol for which anxious and depressive symptoms are 
assessed. I will be provided access to a treatment resource manual containing information 
about self-help books and local treatment services. 
 
C. CONDITIONS OF PARTICIPATION 
I understand that the study will take approximately 60 minutes to complete. I understand 
that I am free to withdraw my consent and discontinue my participation in this study at 
any time, without any negative consequences whatsoever. I understand that all 
information obtained will be kept strictly confidential and will be stored under lock and 
key for a period of seven years after which it will be shredded. Access to this information 
will be made available only to restricted members of Dr. Radomsky’s research team. I 
understand that to ensure my confidentiality all data will be coded by number only and 
will be kept separate from my name. I understand that data from this study may be 
published, but that no identifying information will be released. 
 
If you have any questions concerning the study, please feel free to ask the experimenter 
now. If other questions or concerns come up following the study, please feel free to 
contact our lab at (514) 848-2424, ext. 5965. 
 
Adam S. Radomsky, Ph.D., Associate Professor 






I HAVE CAREFULLY STUDIED THE ABOVE AND UNDERSTAND THIS 
AGREEMENT. I FREELY CONSENT AND VOLUNTARILY AGREE TO 
PARTICIPATE IN THIS STUDY. 
 
NAME (please print) __________________________________       
  




WITNESS SIGNATURE _______________________________ 
 
Please contact the Research Ethics and Compliance Advisor of Concordia University, at 






CONSENT FORM TO PARTICIPATE IN RESEARCH  
 
As you have just been informed, the use of deceptive information was essential in this 
study in order to simulate a real treatment session for contamination fear. During these 
real treatment sessions, individuals are exposed to the contaminants that they fear. 
 
By signing below you indicate that you have been informed of this minor deception and 
allow us to include your results in our analyses. Given the nature of this deception, we 











If you have any questions concerning this study, please feel free to ask the researcher or 
call the lab at 848-2424, ext. 5965. 
 
Adam Radomsky, Ph.D., Associate Professor 






















Initial information and consent 
Treatment sessions 























Initial Information and consent 
Thank you for coming in to participate in this study. My name is Hannah and I am a 
Master’s student here in the lab. Before we begin the consenting process, I will ask you to 
please turn off your cell phone. Thank you. 
 
This study aims to evaluate two versions of an existing treatment for contamination fear, 
which is fear of objects that are perceived as dirty, disgusting, illness-causing, et cetera. 
You will be asked to approach two contaminants in each version of the treatment, as 
close as you are able, and then provide an anxiety rating. After approaching the two 
contaminants in each version of the treatment, you will be asked to complete several 
questionnaires that evaluate the version of treatment you have just completed. At the 
conclusion of the study, you will be fully debriefed about the purposes of the study as 
well as the hypotheses. The study will take approximately 45 minutes, and you will be 
offered one participant pool credit for your participation. If you are not in a pool class, we 
will offer you entry into a draw for one of four cash prizes.  
 
Please note that the information you will provide will be kept strictly confidential. Any 
identifying information will be kept under lock and key for seven years, at which time it 
will be shredded. We will separate any identifying information from your data so it 
cannot be linked back to you. 
 
As a voluntary participant, you are free to withdraw your participation in this study at any 
time without negative consequence. 
 
Before we begin, I’m going to ask that you read through and sign this consent form 
indicating that you are willing to participate and understand what your participation 
entails. Please sign and date at the bottom of the consent form if you agree to the 
conditions. 
 













Treatment sessions and questionnaires 
Now we will begin with the [first/second] version of treatment, which includes two 
contaminants. Please wait here while I get the materials. 
 
FOR LAUNDRY: This is a box of dirty laundry. It includes socks, underwear, old t-
shirts, and rags. Some of these items may have been touched with bodily fluids. 
 
FOR DIRT: This is a mixture of dirt, dead insects, and animal hair.  
 
IF ESB SESSION: Here is a pair of latex-free gloves that might be helpful to you while 
you’re approaching the [dirt, laundry]. Please put them on. 
 
Now tell me, how likely are you to touch this contaminant on a scale from 0-100, 0 being 
not at all likely and 100 being extremely likely, I will most certainly touch it?  
 
ANTICIPATORY SUDS: Please indicate on a scale from 0 to 100, 0 being neutral and 
100 being the worst distress you can imagine, how anxious you feel right now.  
 
Now I will ask you to approach this contaminant in a stepwise fashion. The first step is to 
start here [indicate tape on floor, furthest from the table] and walk as close to the [dirt, 
laundry] as you are able.  
 
Great. The next step is to take a tissue and touch the [dirt, laundry] with it.  
 
Good. The next step is to touch the [dirt, laundry] with your right index finger. 
 
Good. The next step is to touch the [dirt, laundry] with your right hand. 
 
Great. The next step is to touch the [dirt, laundry] with both hands. 
 
Good. The last step is to touch the [dirt, laundry] with both hands, then rub your hands 
together.  
 
PEAK SUDS RATING: Please indicate on a scale from 0 to 100, 0 being neutral and 100 
being the worst distress you can imagine, how anxious you feel right now.  
 
MANIPULATION CHECK: On a scale from 0-100, 0 being not at all contaminated and 
100 being the most you can imagine, how contaminated is the object you just touched?  
 
Thank you.   
 
Now you will begin approaching the second contaminant. Please wait here while I get the 
materials. [If ESB session] You can leave your gloves on. 
 






FOR TOILET: This is a dirty toilet.  
 
Now tell me, how likely are you to touch [the inside of the toilet bowl, the inside rim of 
the bedpan] on a scale from 0-100, 0 being not at all likely and 100 being extremely 
likely, I will most certainly touch it?  
 
ANTICIPATORY SUDS: Please indicate on a scale from 0 to 100, 0 being neutral and 
100 being the worst distress you can imagine, how anxious you feel right now.  
 
Now I will ask you to approach this contaminant in a stepwise fashion. The first step is to 
start here [indicate tape on floor, furthest from the table or toilet] and walk as close to the 
[toilet, bedpan] as you are able.  
 
Great. The next step is to take a tissue and touch the [inside of the toilet bowl, inside rim 
of the bedpan] with it.  
 
Good. The next step is to touch the [inside of the toilet bowl, inside rim of the bedpan] 
with your right index finger. 
 
Good. The next step is to touch the [inside of the toilet bowl, inside rim of the bedpan] 
with your right hand. 
 
Great. The next step is to touch the [inside of the toilet bowl, inside rim of the bedpan] 
with both hands. 
 
Good. The last step is to touch the [inside of the toilet bowl, inside rim of the bedpan] 
with both hands, then rub your hands together.  
 
PEAK SUDS RATING: Please indicate on a scale from 0 to 100, 0 being neutral and 100 
being the worst distress you can imagine, how anxious you feel right now.  
 
MANIPULATION CHECK: On a scale from 0-100, 0 being not at all contaminated and 
100 being the most you can imagine, how contaminated is the object you just touched?  
 
Thank you. Now, I’ll ask you to complete four questionnaires on this computer that 
evaluate the version of treatment you've just completed, which includes both of the 
contaminants. By treatment I mean what we’ve just done, approaching the contaminants 
in a stepwise fashion [if ESB session: with gloves on]. Remember there are no right or 
wrong answers. Please don’t worry too much about any one item. Usually your first 
instinct is the best answer. When you’ve finished the four questionnaires, the screen will 
say “Please stop here and wait for the experimenter.” If I’m not back by that point, you 







Final Questionnaire Battery 
Now I’ll ask you to complete some more questionnaires on this computer. Remember 
there are no right or wrong answers. Please don’t worry too much about any one item.  
Usually your first instinct is the best answer. I’m going to leave you alone to complete 
















Okay, that concludes the experiment. We just have a few things to go through before you 
leave. First, let’s discuss this consent form. As the form indicates, this study did not use 
real contaminants. The clothing you approached was not actually touched by bodily 
fluids. The toilet you approached was bought new and smeared with wet potting soil. The 
bedpan you approached was filled with dilute apple juice.  
We needed to use some deception in this study in order to simulate a real treatment 
session for contamination fear. During real treatment sessions, patients are exposed to the 
contaminants that they fear the most, similar to the way you were exposed to various 
objects during this study. Because we used deception, we are required to ask you to fill 
out this form indicating that you understand why deception was used, and that you agree 
to let us use your data. Please read through the form and sign if you agree to the terms. 
Please do not discuss this study with anyone, so as not to give away the true nature of the 
study. 
I would also like to review our debriefing form with you. As I mentioned at the beginning 
of the study, this study aims to evaluate various components of a treatment for 
contamination fear. This treatment can be very difficult for people that have significant 
contamination fears, as it involves exposing them to the contaminants they are most 
afraid of. Our intention is to modify this treatment to make it less difficult for people, 
which is why you were offered a pair of gloves before approaching some of the 
contaminants. Please take a minute to review this debriefing form. Also, there is a section 
of the form that provides you access to our online treatment manual, in case you or 
someone you know is having problems with anxiety and depression. 
Please do not leave this form lying around in case someone should find it. Any last 
questions? 
IF THIS IS A POOL PARTICIPANT: You will be credited for your participation using 
the online system, and you will receive a confirmation email once the credit has been 
given. Please be sure to keep this email for your records. 
IF THIS IS A CASH DRAW PARTICIPANT: If you win one of the four cash prizes, you 
will be contacted via email to receive your prize. 

















Thank you for your time and cooperation. The purpose of this study is to evaluate 
different components of cognitive-behavioural treatment for contamination fear. This 
treatment can be particularly difficult for individuals with significant contamination fear, 
because it often involves exposure to contaminants they are very afraid of. For this 
reason, many people refuse the treatment entirely, or drop out before the treatment has a 
chance to help them. In conducting this study, our intention is to modify this treatment to 
make it more tolerable for people with significant fears. This is why you were offered a 
pair of latex-free gloves before approaching some of the contaminants, because we 
thought the gloves might make the approach easier for you. We hypothesize that 
participants will rate the condition in which they were offered gloves as more tolerable 
than the condition in which they did not have gloves. We also hypothesize that 
individuals with significant contamination fears will rate the gloves condition as even 
more tolerable than the no-gloves condition compared to people without significant fears.  
 
If you have any questions or comments about this study or to contact the laboratory for 
your compensation, please contact Hannah Levy (ha_levy@live.concordia.ca; 514-848-
2424, ext. 5965) or Dr. Adam Radomsky (adam.radomsky@concordia.ca).  If you are 
interested in the results of this study, you may contact Hannah Levy at the completion of 
the study.  Note that only global results, not individual results, will be released.   
 
In our research, we ask you many questions about feelings related to anxiety and sadness. 
If at any time you feel that you need help related to these feelings or other problems, 
please go to the treatment manual on our website for information on local resources (see 
below). Also, please don’t hesitate to contact us at the lab with any questions or concerns 
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